Pharmacists can use their knowledge and professional judgment to educate patients about when it is appropriate to take these medications and when to avoid them.
Taking a few seconds to double-check a prescription can have significant impacts on patient safety
Pharmacists can play a key role in providing education and guidance to patients with glaucoma.
The expanded role of oncology pharmacists includes the opportunity to work in ambulatory settings, infusion centers, delivery of specialized in pharmacy services, evaluation of investigational new drugs, and manager roles in drug chain supply and in coordination of care.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
Because decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
RSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.
Challenges remain, however, to therapy development for a limited patient population.
How patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers.
Texting with patients can help to improve pharmacy processes while creating better user experiences.
Gene therapies in late-stage development may soon provide hope for a cure.
With more work and less staff, we need to examine how we can better support pharmacists in the new normal brought on by COVID-19.
In January 2024, Florida became the only state to allow the importation of medications for public use.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Advances, challenges, and promising innovations emerge.
Researchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations
The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Adaptability, teamwork, and a culture of lifetime learning are required virtues in our rapidly evolving medical landscape.
High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
AI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Professional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
Pharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
The relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
The exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.